Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

CELL-MATRIX MICROSPHERES, METHODS FOR PREPARATION AND APPLICATIONS


总结

A method has been developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency and high cell viability, using matrix or biomaterial systems with poor shape and mechanical stability for applications including cell therapeutics via microinjection or surgical implantation, 3D culture for in vitro expansion without repeated cell splitting using enzymatic digestion or mechanical dissociation and for enhanced production of therapeutic biomolecules, and in vitro modelling for morphogenesis studies. The modified droplet generation method is simple and scalable and enables the production of cell-matrix microspheres when the matrix or biomaterial system used has low concentration, with slow phase transition, with poor shape and mechanical stability.


附加资料

Patent Number: US8679809B2
Application Number: US2007750863A
Inventor: Chan, Barbara Pui | Chan, Godfrey Chi-Fung | Wong, Hoi Ling | Cheung, Pik To | Cheah, Song-Eng Kathryn | Chan, Danny
Priority Date: 19 May 2006
Priority Number: US8679809B2
Application Date: 18 May 2007
Publication Date: 25 Mar 2014
IPC Current: C12N001104 | C12N0005077 | C12N00050775
US Class: 435177 | 4240937
Assignee Applicant: The University of Hong Kong
Title: Cell-matrix microspheres, methods for preparation and applications
Usefulness: Cell-matrix microspheres, methods for preparation and applications
Summary: The cell-matrix microsphere can be used for producing a biomolecule and for injecting or implanting into tissues of animals or humans (claimed), for tissue repair or regeneration, e.g. for skin wound or an injured cartilage. It can also be used as therapeutics, and as three-dimensional (3D) microcarriers. The cell-matrix microspheres can also be used to immobilize other therapeutic molecules, e.g. factors inducing specific differentiation lineage such as Transforming Growth Factor (TGF) beta for chondrogenic differentiation, and anti-inflammatory drugs.
Novelty: New cell-matrix microspheres comprises an extracellular matrix forming a nanofibrous microsphere, useful for producing a biomolecule and for injecting or implanting into tissues of animals or humans for tissue repair or regeneration


主要类别

诊断/治疗


细分类别

其他疾病


申请号码

CN200780018296A


国家/地区

香港

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版